Seeking Alpha

The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and...

The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and above. The vaccine is the first one for the illness that's produced using cultured animal cells rather than fertilized chicken eggs. That should allow mass production to begin faster if there's a pandemic.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs